Bulletin
Investor Alert

Moderna Inc.

NAS: MRNA

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

May 27, 2022, 7:59 p.m.

/zigman2/quotes/205619834/composite

$

146.90

Change

-0.76 -0.51%

Volume

Volume 123,115

Quotes are delayed by 20 min

/zigman2/quotes/205619834/composite

Previous close

$ 135.80

$ 147.66

Change

+11.86 +8.73%

Day low

Day high

$136.59

$148.54

Open

52 week low

52 week high

$119.01

$497.49

Open

Robert S. Langer

Founder of 41 different companies, notably: Moderna, Inc., Momenta Pharmaceuticals, Inc. and Seer, Inc. (California), Robert S. Langer is an entrepreneur and presently is Advisor at aMoon Ventures Y Sh Ltd., Non-Executive Director at Puretech Health LLC (which he founded in 2000) and advisor at Healthcare Royalty Management LLC. Dr. Langer is also Professor at Massachusetts Institute of Technology and Professor at David H. Koch Institute for Integrative Cancer Research and on the board of 33 other companies.

In his past career he held the position of Director at Combinent BioMedical Systems, Inc. (he founded the company in 2009), Specialists at The Water Initiative LLC, Board Advisor at Celero Systems, Inc. (he founded the company), Chairman-Science Board at US Food & Drug Administration, Member of National Academy of Sciences, Member of National Academy of Engineering, Member of National Academy of Medicine (United States), Director at Momenta Pharmaceuticals, Inc., Director at Pervasis Therapeutics, Inc., Director at DNIB Unwind, Inc., Director at Semprus BioSciences Corp., Director at Selecta Biosciences, Inc., Director at Kala Pharmaceuticals, Inc., Director at SQZ Biotechnologies Co., Director at Living Proof, Inc., Director at Microchips Biotech, Inc., Director at T2 Biosystems, Inc., Director at Lyra Therapeutics, Inc., Director at Tarveda Therapeutics, Inc. and Director at Sigilon Therapeutics, Inc.

He received an undergraduate degree from Cornell University and a doctorate from Massachusetts Institute of Technology.

Transactions

Date Shares Transaction Value
04/28/2022 703   Derivative/Non-derivative trans. at $0 per share. 0
12/11/2018 4,559   Derivative/Non-derivative trans. at $0 per share. 0

Officers and Executives

Mr. Stéphane Bancel
Chief Executive Officer & Director
Dr. Stephen Hoge
President
Mr. David W. Meline
Chief Financial Officer
Dr. Paul Burton
Chief Medical Officer
Mr. Juan Andres
Chief Technical Operations & Quality Officer
Dr. Melanie Ivarsson
Chief Development Officer
Dr. Jacqueline Miller
Senior VP-Infectious Disease Development
Mr. Patrick Norman Bergstedt
Senior Vice President-Commercial Vaccines
Mr. Raymond C. Jordan
Chief Corporate Affairs Officer
Mr. John Lepore
Senior Vice President-Government Engagement
Dr. José M. Vega
Chief Safety Officer
Ms. Kate Cronin
Chief Brand Officer
Mr. Jonathan Hoggatt
Director-Hematology
Mr. Michael Mullette
Managing Director-Canada
Mr. Marcello Damiani
Chief Digital & Operational Excellence Officer
Ms. Lavina A. Talukdar
Senior Vice President & Head-Investor Relations
Ms. Tracey Franklin
Chief Human Resources Officer
Dr. Shannon Thyme Klinger
Secretary & Chief Legal Officer
Dr. Charbel Haber
Senior Vice President-Regulatory Affairs
Dr. Paula Hammond
Scientific Advisory Board
Dr. Noubar B. Afeyan
Chairman
Dr. Francois Nader
Independent Non-Executive Director
Dr. Sandra J. Horning
Independent Director
Ms. Elizabeth E. Tallett
Independent Director
Dr. Elizabeth G. Nabel
Independent Director
Mr. Paul L. Sagan
Independent Non-Executive Director
Dr. Robert S. Langer
Independent Non-Executive Director
Mr. Stephen A. Berenson
Independent Non-Executive Director
Link to MarketWatch's Slice.